Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1Phase 2/3 1Phase 2 1

Status

Recruiting 3Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5Observational 1

Sponsor

Cancer Type

Classical hematology 5Plasma cell 2Other hematologic neoplasm 1Lymphoid 1Gynecologic 1Genitourinary 1

Conditions

Venous Thromboembolism 4Multiple Myeloma 2Urologic Neoplasms 1Urogenital Neoplasms 1Pulmonary Embolism 1Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery 1Neoplasms 1Lymphoma 1Leukemia 1Hematologic Neoplasms 1

Interventions

pembrolizumab 1254Specimen Handling 869Carboplatin 818Magnetic Resonance Spectroscopy 804Cyclophosphamide 795Cisplatin 716Nivolumab 648Paclitaxel 623Radiotherapy 567Gemcitabine 565Biopsy 529Bevacizumab 468Dexamethasone 434fludarabine 404Docetaxel 373venetoclax 366Oxaliplatin 362Capecitabine 353Fluorouracil 352atezolizumab 341Rituximab 327durvalumab 326Doxorubicin 313Radiosurgery 306Pemetrexed 303Drug Therapy 295Standard of Care 292Ipilimumab 290Etoposide 280Radiation 278

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Interventional × Rivaroxaban × 1 year × Clear all
NCT07270263 2025-12-26

HEM-DOAC

Medical University of Gdansk

Phase NA Recruiting
100 enrolled
Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Multiple Myeloma, Pulmonary Embolism, Hematologic Neoplasms, Venous Thromboembolism

NCT06220123 2025-07-22

A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery

Beijing Suncadia Pharmaceuticals Co., Ltd

Phase 2 Completed
225 enrolled
Classical hematologyGynecologic

Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery

NCT06580223 2025-07-18

Aspirin or Rivaroxaban Thromboprophylaxis for Patients With Multiple Myeloma

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Phase 3 Not yet recruiting
530 enrolled
Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism

NCT05920343 2025-07-10

PREVENT-GU

Ottawa Hospital Research Institute

Phase 2/3 Recruiting
120 enrolled
Classical hematologyGenitourinary

Urogenital Neoplasms, Urologic Neoplasms, Venous Thromboembolism

NCT05029063 2025-07-09

TRIM-Line

Ottawa Hospital Research Institute

Phase 3 Recruiting
1,828 enrolled
Classical hematology

Neoplasms, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡